Experience with degarelix in the treatment of prostate cancer
Degarelix is a gonadotrophin-releasing hormone (GnRH) antagonist for the first-line treatment of androgen-dependent advanced prostate cancer. It has a direct mechanism of action that blocks the action of GnRH on the pituitary with no initial surge in gonadotrophin or testosterone levels. Degarelix i...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
SAGE Publishing
2013-02-01
|
| Schriftenreihe: | Therapeutic Advances in Urology |
| Online-Zugang: | https://doi.org/10.1177/1756287212461048 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|